Moleculin Biotech

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MBRX and other ETFs, options, and stocks.

About MBRX

Moleculin Biotech, Inc. is a clinical stage pharmaceutical company. It engages in the business of growing a pipeline including phase 2 clinical programs for hard-to-treat cancers and viruses.

CEO

Walter V. Klemp

CEOWalter V. Klemp

Employees

Employees18

Headquarters

Houston, Texas

HeadquartersHouston, Texas

Founded

2015

Founded2015

Employees

Employees18

MBRX Key Statistics

Market cap

10.67M

Market cap10.67M

Price-Earnings ratio

-0.29

Price-Earnings ratio-0.29

Dividend yield

—

Dividend yield—

Average volume

17.94K

Average volume17.94K

High today

$4.90

High today$4.90

Low today

$4.28

Low today$4.28

Open price

$4.50

Open price$4.50

Volume

23.05K

Volume23.05K

52 Week high

$15.75

52 Week high$15.75

52 Week low

$4.28

52 Week low$4.28

MBRX News

Yahoo Finance 1d

Moleculin Biotech Participates in Virtual Investor "What This Means" Segment Hosted by JTC Team - Yahoo Finance

Moleculin CEO, Walter Klemp highlights Annamycin differentiation in the current AML treatment landscape and potential opportunity FRENCHTOWN, NJ / ACCESSWIRE /...

TipRanks 1d

Moleculin Biotech Shares Corporate Direction Insights - TipRanks.com - TipRanks

Moleculin Biotech (MBRX) just unveiled an update. Moleculin Biotech, Inc. has released a corporate presentation on its website, sharing insights into the compa...